Adverse reactions to duloxetine in depression

Using Second-Generation Antidepressants to Treat Depressive Disorders: A Clinical Practice Guideline from the American College of Physicians

(2013) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

Atypical Stevens-Johnson Syndrome in an Adolescent Treated with Duloxetine

(2011) Jeffrey R. Strawn et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Profile of Adverse Events with Duloxetine Treatment

(2010) Stephen Brunton et al.   DRUG SAFETY

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

(2010) Michele Mancini et al.   EXPERT OPINION ON PHARMACOTHERAPY

Duloxetine 60 mg/day for the prevention of depressive recurrences:post hocanalyses from a recurrence prevention study

(2010) K. Kelin et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Why Do You Need to Move Beyond First-Line Therapy for Major Depression?

(2010) Larry Culpepper   JOURNAL OF CLINICAL PSYCHIATRY

Continuation treatment of major depressive disorder: is there a case for duloxetine?

(2010) Trevor Norman   Drug Design Development and Therapy

Adverse events, toxicity and post-mortem data on duloxetine: Case reports and literature survey

(2010) Eric L. Vey et al.   Journal of Forensic and Legal Medicine

Use of Duloxetine in Pregnancy and Lactation

(2009) Gerald G Briggs et al.   ANNALS OF PHARMACOTHERAPY

Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low

(2009) Scott B Patten   BMC Psychiatry

In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine

(2009) Evelyn D Lobo et al.   CLINICAL PHARMACOKINETICS

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review

(2009) Marco Tuccori et al.   CLINICAL THERAPEUTICS

Duloxetine

(2009) Natalie J. Carter et al.   CNS DRUGS

The General and Comparative Efficacy and Safety of Duloxetine in Major Depressive Disorder

(2009) Gerald Gartlehner et al.   DRUG SAFETY

Duloxetine in the management of elderly patients with major depressive disorder: an analysis of published data

(2009) M Mancini et al.   EXPERT OPINION ON PHARMACOTHERAPY

Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine

(2009) Madhukar H. Trivedi et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Plasma levels and cerebrospinal fluid penetration by duloxetine in a patient with a non-fatal overdose during a suicide attempt

(2009) Michael Paulzen et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Randomized, Double-Blind Study of Increasing or Maintaining Duloxetine Dose in Patients Without Remission of Major Depressive Disorder After Initial Duloxetine Therapy

(2009) Susan G. Kornstein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

(2009) Andrew J. Cutler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Safety and Tolerability of Duloxetine at 60 mg Once Daily in Elderly Patients With Major Depressive Disorder

(2009) Joel Raskin et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Treatment-Emergent Sexual Dysfunction Related to Antidepressants

(2009) Alessandro Serretti et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

(2009) Andrea Cipriani et al.   LANCET

Placental Transfer of SSRI and SNRI Antidepressants and Effects on the Neonate

(2009) J. Rampono et al.   PHARMACOPSYCHIATRY

Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety

(2008) D. Taylor   ACTA PSYCHIATRICA SCANDINAVICA

Poor Neonatal Adaptation After in Utero Exposure to Duloxetine

(2008) ROY EYAL et al.   AMERICAN JOURNAL OF PSYCHIATRY

Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women

(2008) Evelyn D Lobo et al.   CLINICAL PHARMACOKINETICS

The hepatic safety profile of duloxetine: a review

(2008) Roger S McIntyre et al.   Expert Opinion on Drug Metabolism & Toxicology

Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System

(2008) Sheldon H. Preskorn et al.   Journal of Psychiatric Practice

Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial

(2008) S. Englisch et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial☆

(2008) Jon I. Russell et al.   PAIN

Prioritizing Future Research on Off-Label Prescribing: Results of a Quantitative Evaluation

(2008) Surrey M Walton et al.   PHARMACOTHERAPY

Non-fatal overdose of duloxetine in combination with other antidepressants and benzodiazepines

(2008) Marco Menchetti et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder

(2007) David L. Dunner et al.   DEPRESSION AND ANXIETY

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

(2007) David G.S. Perahia et al.   JOURNAL OF PSYCHIATRIC RESEARCH